Answers are grounded in this paper and cite their sources.
, β-sheet and β-turn conformations), and cyclic architecture, as supported by recent dual-target peptide studies, and converge multiple signaling pathways, including glucagon-like peptide-1 receptor (GLP-1R), brain-derived neurotrophic factor/tropomyosin receptor kinase B (BDNF/TrkB), hypothalamic-pituitary-adrenal (HPA) axis, AMP-activated protein kinase (AMPK), phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt), and inflammatory pathways, highlighting their potential for multitarget intervention in metabolic-emotional comorbidities. The review further explores the prospects and challenges of applying these peptides in functional foods, drug delivery systems, and personalized nutrition interventions, emphasizing the need for in-depth research on target complexity, delivery system optimization, and clinical translation to advance the practical application of multifunctional peptides in treating comorbid metabolic and emotional disorders.
No takes yet. Share an insight, caveat, or question.
Yao-zhu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: